Euphraxia Pharmaceuticals to secure debt funding from SVB
Victoria, British Columbia-based biotechnology company Eupraxia Pharmaceuticals has entered into a C$10 million convertible debt agreement.
22 June 2021•5 mins read
Victoria, British Columbia-based biotechnology company Eupraxia Pharmaceuticals has entered into a C$10 million convertible debt agreement.
